NewsLagomics named NIH NCATS OligoTox Phase 1 winner→
LAGOMICS
How it worksApplicationsAboutNewsLagom NotesGet in touch
How it worksApplicationsAboutNewsLagom NotesGet in touch

Applications

Where our molecules go

We design functional proteins and advance them toward product. Therapeutic programs we drive through development. Active ingredients we take through formulation and partnership to market.

Therapeutic programs

We are advancing internal therapeutic programs in women's health, with the same platform at therapeutic-grade stringency. We drive development through preclinical and clinical milestones, with partners on specific capabilities.

Active ingredients

We develop novel protein-based actives with measured interaction and functional data. We advance them through formulation and work with ingredient partners to bring them to market.

LAGOMICS

Supported by

Activate FellowshipMIT Engine BlueprintNVIDIAMBC Biolabs

© 2026 Lagomics. All rights reserved.